Lack of Nephrotoxicity with the Administration of Amphotericin B in a Lipid Emulsion

Smith, Timothy M.; Strozyk, William R.

doi:10.1177/106002809402801125

Cited by 10 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Amphotericin, intravenous acyclovir, and vancomycin with piperacillin/ tazobactam (combination) are associated with AKI. 133,134 Calcineurin inhibitors (CNIs) play a major role as contributors to AKI after HSCT. 135 In addition to renal vessel vasoconstriction, CNIs can lead to tubular toxicity, renal endothelial damage, and TMA.…”

Section: Acute Kidney Injury With Hsctmentioning

confidence: 99%

See 1 more Smart Citation

Onconephrology: The intersections between the kidney and cancer

Rosner

Jhaveri

McMahon

et al. 2020

CA A Cancer J Clinicians

101

View full text Add to dashboard Cite

Onconephrology is a new subspecialty of nephrology that recognizes the important intersections of kidney disease with cancer. This intersection takes many forms and includes drug-induced nephrotoxicity, electrolyte disorders, paraneoplastic glomerulonephritis, and the interactions of chronic kidney disease with cancer. Data clearly demonstrate that, when patients with cancer develop acute or chronic kidney disease, outcomes are inferior, and the promise of curative therapeutic regimens is lessened. This highlights the imperative for collaborative care between oncologists and nephrologists in recognizing and treating kidney disease in patients with cancer. In response to this need, specific training programs in onconephrology as well as dedicated onconephrology clinics have appeared. This comprehensive review covers many of the critical topics in onconephrology, with a focus on acute kidney injury, chronic kidney disease, drug-induced nephrotoxicity, kidney disease in stem cell transplantation, and electrolyte disorders in patients with cancer.

show abstract

Section: Acute Kidney Injury With Hsctmentioning

confidence: 99%

“…Both sepsis and antimicrobial agents may increase the risk of AKI. Amphotericin, intravenous acyclovir, and vancomycin with piperacillin/tazobactam (combination) are associated with AKI 133,134 . Calcineurin inhibitors (CNIs) play a major role as contributors to AKI after HSCT 135 .…”

Section: Kidney Disease Associated With Hsctmentioning

confidence: 99%